3 of the biggest T1D stories of April 2024

Featured Podcast Episode
April 26, 2024

April is already over?! It’s almost time to stock up on sunscreen and put those winter clothes in the attic. Here are 3 of the biggest T1D stories to hit the news this past month:

1 // Humalog & Novolog shortages: Eli Lilly has begun shipping 10mL vials of Humalog again and believes they’ll be able to catch up to patient demands soon.  Novo Nordisk also has a shortage of 10mL vials of NovoLog but has plenty of stock of their FlexPens and PenFill. Read more here: https://www.jdrf.org/press-releases/jdrf-statement-and-update-on-insulin-shortage/

2 // Twiist insulin pump unveiled by CEO Alan Lotvin: The new Twiist insulin pump powered by the Tidepool Loop algorithm announced in March is finally seen on Stacey Simms Diabetes Connections podcast. It’s FDA-approved and will be available later this year. Quick video showing Twiist: https://www.youtube.com/watch?v=-wj0egIRnfg

3 // Trial studying beta cell stimulation for T1D: Biomea Fusion is in a Phase 2 Trial of BMF-219, an oral medication that helps block a protein, preventing beta cells from growing too much. This could allow beta cells to be restored over time, which has been successful in Type 2 Diabetes trials. More info: https://diatribe.org/join-trial-studying-beta-cell-stimulation-type-1-diabetes